Electromed, Inc. (ELMD)

NYSEAMERICAN: ELMD · IEX Real-Time Price · USD
16.41
+0.15 (0.92%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Company Description

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.

The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases.

It markets its products primarily to physicians and health care providers, as well as directly to patients.

Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Electromed, Inc.
Electromed logo
Country United States
Founded 1992
IPO Date Aug 13, 2010
Industry Medical Devices
Sector Healthcare
Employees 170
CEO James L. Cunniff

Contact Details

Address:
500 Sixth Avenue Nw
New Prague, Minnesota 56071
United States
Phone 952-758-9299
Website smartvest.com

Stock Details

Ticker Symbol ELMD
Exchange NYSEAMERICAN
Fiscal Year July - June
Reporting Currency USD
CIK Code 0001488917
CUSIP Number 285409108
ISIN Number US2854091087
Employer ID 41-1732920
SIC Code 3845

Key Executives

Name Position
Bradley M. Nagel Chief Financial Officer
James L. Cunniff President, Director and Chief Executive Officer
William J. George Secretary

Latest SEC Filings

Date Type Title
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 10-Q Quarterly Report
Feb 13, 2024 8-K Current Report
Dec 15, 2023 8-K Current Report
Nov 30, 2023 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Nov 30, 2023 S-8 Securities to be offered to employees in employee benefit plans
Nov 15, 2023 8-K Current Report
Nov 7, 2023 10-Q Quarterly Report
Nov 7, 2023 8-K Current Report